Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Huebner

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Current Oncology (Toronto, Ont.)|February 24, 2023
Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate CancerBernhard Grubmüller, Nicolai A Huebner, Sazan Rasul, et al.
Urologic Oncology|April 21, 2026
Venous thromboembolism in patients with urothelial carcinoma receiving systemic therapyIrene Huebner-Resch, Nicolai A Huebner, Regina Girgis, et al.
The American Journal of Surgical Pathology|August 21, 2015
Tactile Corpuscle-like Bodies in Gastrointestinal-type Mucosa: A Case SeriesCatuxa Celeiro-Muñoz, Thomas A Huebner, Scott A Robertson, et al.
Elife|December 6, 2017
Deciphering caveolar functions by <i>syndapin III</i> KO-mediated impairment of caveolar invaginationEric Seemann, Minxuan Sun, Sarah Krueger, et al.
European Journal of Clinical Investigation|March 6, 2024
Focal high-intensity focused ultrasound therapy for localized prostate cancer: An interim analysis of the multinational FASST studySam Ladjevardi, Anna Ebner, Aleksandar Femic, et al.
The Journal of Urology|April 27, 2021
The Prognostic Association of Prostate MRI PI-RADS™ v2 Assessment Category and Risk of Biochemical Recurrence after Definitive Local Therapy for Prostate Cancer: A Systematic Review and Meta-AnalysisPawel Rajwa, Keiichiro Mori, Nicolai A Huebner, et al.
Clinical Endocrinology|September 30, 2000
Tall stature in familial glucocorticoid deficiencyL L Elias, A Huebner, L A Metherell, et al.
Journal of Medical Genetics|November 3, 2004
Missense mutations of ACTA1 cause dominant congenital myopathy with coresA M Kaindl, F Rüschendorf, S Krause, et al.
BJU International|September 12, 2024
Differences in mutations across tumour sizes in clear-cell renal cell carcinomaSteven M Monda, Benjamin W Carney, Allison M May, et al.
Urologic Oncology|January 21, 2024
Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PETNicolai A Huebner, Gabriel Wasinger, Pawel Rajwa, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Current Oncology (Toronto, Ont.)|February 24, 2023
Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate CancerBernhard Grubmüller, Nicolai A Huebner, Sazan Rasul, et al.
Urologic Oncology|April 21, 2026
Venous thromboembolism in patients with urothelial carcinoma receiving systemic therapyIrene Huebner-Resch, Nicolai A Huebner, Regina Girgis, et al.
The American Journal of Surgical Pathology|August 21, 2015
Tactile Corpuscle-like Bodies in Gastrointestinal-type Mucosa: A Case SeriesCatuxa Celeiro-Muñoz, Thomas A Huebner, Scott A Robertson, et al.
Elife|December 6, 2017
Deciphering caveolar functions by <i>syndapin III</i> KO-mediated impairment of caveolar invaginationEric Seemann, Minxuan Sun, Sarah Krueger, et al.
European Journal of Clinical Investigation|March 6, 2024
Focal high-intensity focused ultrasound therapy for localized prostate cancer: An interim analysis of the multinational FASST studySam Ladjevardi, Anna Ebner, Aleksandar Femic, et al.
The Journal of Urology|April 27, 2021
The Prognostic Association of Prostate MRI PI-RADS™ v2 Assessment Category and Risk of Biochemical Recurrence after Definitive Local Therapy for Prostate Cancer: A Systematic Review and Meta-AnalysisPawel Rajwa, Keiichiro Mori, Nicolai A Huebner, et al.
Clinical Endocrinology|September 30, 2000
Tall stature in familial glucocorticoid deficiencyL L Elias, A Huebner, L A Metherell, et al.
Journal of Medical Genetics|November 3, 2004
Missense mutations of ACTA1 cause dominant congenital myopathy with coresA M Kaindl, F Rüschendorf, S Krause, et al.
BJU International|September 12, 2024
Differences in mutations across tumour sizes in clear-cell renal cell carcinomaSteven M Monda, Benjamin W Carney, Allison M May, et al.
Urologic Oncology|January 21, 2024
Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PETNicolai A Huebner, Gabriel Wasinger, Pawel Rajwa, et al.
Pageof 12